Our Goal

Empower people everywhere to protect themselves from infectious diseases.

In recent years, we’ve seen our healthcare system become overwhelmed in efforts to protect people from infectious diseases. With Nearly 9 out of 10 Americans* have gaps in immunity, a new line of defense is needed. At ImmunoProfile, we envision a different way forward, where people are able to own their protection. It all starts with knowing your level of personal protection from infectious diseases.

We believe this is the future – and we are developing the science to make this accessible and affordable.

* Centers for Disease Control and Prevention (CDC), Morbidity and Mortality Weekly Report, May 14, 2021, “Surveillance of Vaccination Coverage Among Adult Populations — United States, 2018”

Scientifically Tested
Family and Loved Ones Protection

Technology that makes all the difference with specimen collection at home

Today, antibody testing to determine vulnerability to infectious disease means having blood drawn at a medical facility. We have developed technology that allows you to know your antibody status without leaving home.

With a simple fingerprick and our unique testing kit, we are able to assess antibody status to an entire panel of infectious diseases. For families, employers, military, schools, senior centers, individuals and more – it has the potential to change the way we assess risk and ensure protection.

Proven Leadership Team

Sudip Ghatak

Sudip Ghatak

Chief Technology Officer 

Mr. Sudip Ghatak, Chief Technology Officer, brings over 25 years of medical diagnostics and device leadership in product development, innovation, strategy, and marketing to the ImmunoProfile®  team. Prior to his role with ImmunoProfile® , Mr. Ghatak held various management positions at Abbott Laboratories, Ikaria, PA Consulting Group, Sarnoff Corporation, and Genentech.
Mr. Ghatak holds Bachelor of Science and Arts degrees in Molecular and Cell Biology, and Geography from the Univeristy of California, Berkely, as well as a Masters of Business Administration in Finance and Marketing from New York University.

Mr. William F. Shea – Chief Executive Officer, comes to ImmunoProfile® with over 40 years of medical device leadership. He has served as Chief Executive Officer for three medical companies, and as a Board Member for over a dozen other medical companies. Mr. Shea began his career at The Kendal Company (now part of Medtronic) and later served as CEO of New Dimensions in Medicine, The Clinipad Corporation, and Med-Ecom. Bill has also consulted on numerous medical device transactions representing entrepreneurs with innovative technologies that fit in the portfolios of larger strategic medical companies. He holds a Bachelor of Arts degree in Economics from College of The Holy Cross and an MBA with concentration in Marketing and Finance from Boston University.

William F. Shea

William F. Shea

Chief Executive Officer

Gerald B. Rosenberg

Gerald B. Rosenberg

Director

Mr. Rosenberg, Director, brings a wealth of experience from both the diagnostic and pharmaceutical industries. For four years he served as Senior Vice President and General Manager of Diagnostics for Bayer Healthcare North America. Previously, he held the Senior Vice President and General Manager position for Bayer Healthcare’s Pharmaceuticals division, overseeing the business in the United States. Mr. Rosenberg holds a Bachelor of Science from Boston State College and was awarded his MBA at the University of New Haven.

Dr. Olivo is a physician scientist with over 40 years of experience in academia and industry in the fields of infectious disease and in vitro diagnostic test development. He holds multiple U.S. patents and has developed many diagnostic tests for viral and autoimmune diseases. He was the President and Chief Scientific Officer at Apath, LLC, a hepatitis C virus (HCV)-focused company founded by Nobel laureate Dr. Charles Rice. During his tenure at Apath the company developed and licensed many of the virological tools used by the pharmaceutical industry to develop numerous anti-HCV drugs now used to cure HCV. Dr. Olivo was also the VP of R&D at Diagnostic Hybrids, Inc. an IVD manufacturer acquired by Quidel Corp. At Quidel he served as Senior Medical Director.

Dr. Olivo consults for and serves on the boards of multiple early-stage life science companies. He is a Managing Director and Venture Partner at two seed-stage investment firms. He is also an Adjunct Professor at Washington University Medical School in St. Louis. He received his medical and doctoral degrees from the University of Florida. He did his medical residency in Internal Medicine at the University of Wisconsin where he was chief medical resident. He did his postdoctoral training at the National Institutes of Health in the Laboratory of Viral Diseases.

Paul D. Olivo, M.D., Ph.D.

Paul D. Olivo, M.D., Ph.D.

Chief Medical Officer

John H. Cellucci

John H. Cellucci

Senior Vice President Operations

Mr. John H. Cellucci brings to ImmunoProfile® over 30 years of operations experience on a global basis in manufacturing, product development sales, marketing, corporate development, mergers and acquisitions and legal skills. Prior to ImmunoProfile®, he held various senior management positions including executive operational roles at companies like Johnson Controls, Deloitte Consulting, Fedders Corporation Air Conditioning and Public Service Electric & Gas. John has been a key manager and leader in a variety of business transactions for Fortune 500 companies. He holds a Bachelor of Arts from Villanova University, an MBA and JD from Widener University and an LLM from a joint program between University of Salzburg Austria and McGeorge School of Law. John holds a PMP certification and is licensed to practice law in the states of PA and NJ.

Proven Leadership Team

Sudip Ghatak

Chief Technology Officer 

Mr. Sudip Ghatak, Chief Technology Officer, brings over 25 years of medical diagnostics and device leadership in product development, innovation, strategy, and marketing to the ImmunoProfile® team. Prior to his role with ImmunoProfile®, Mr. Ghatak held various management positions at Abbott Laboratories, Ikaria, PA Consulting Group, Sarnoff Corporation, and Genentech.
Mr. Ghatak holds Bachelor of Science and Arts degrees in Molecular and Cell Biology, and Geography from the Univeristy of California, Berkely, as well as a Masters of Business Administration in Finance and Marketing from New York University.

William F. Shea

Chief Executive Officer

Mr. William Shea, Chief Executive Officer, comes to ImmunoProfile® with over 40 years of experience in medical device leadership. He has serves as Chief Executive Officer of three medical companies and as a Board Member for over a dozen medical companies. Mr. Shea began his career at the Kendal Company (now part of Medtronic) and later served as CEO of New Dimensions in Medicine, the Clinipad Corporation, and Med-Ecom.

Mr. Shea has also consulted on numerous medical device transactions representing entrepreneurs with innovative technologies that fit in the portfolios of larger strategic medical companies. He holds a Bachelor of the Arts degree in Economics from The College if the Holy Cross and an Masters of Business Administration with a concentration in Marketing and Finance from Boston University.

Paul Birkmeyer

Chief Business Officer

Mr. Paul Birkmeyer, Chief Business Officer, has extensive experience in the medical device industry, boasting over 30 years as an executive and entrepreneur across a variety of specialties, including therapeutic, diagnostic, and enabling technologies. Mr. Birkmeyer started and expanded a minimally invasive spine surgery at Johnson & Johnson, including the creation and development of multiple novel technologies to market and exit at a startup.
Mr. Birkmeyer has a broad range of experience, including marketing, sales, education, strategy, new technology, and senior management and involvement with over 10 best-in-class products. He holds a Bachelor of Science in Engineering from the University of Connecticut, and a Masters of Engineering, Engineering Management from Dartmouth College.

Gerald B. Rosenberg

Director

Mr. Rosenberg, Director, brings a wealth of experience from both the diagnostic and pharmaceutical industries. For four years he served as Senior Vice President and General Manager of Diagnostics for Bayer Healthcare North America. Previously, he held the Senior Vice President and General Manager position for Bayer Healthcare’s Pharmaceuticals division, overseeing the business in the United States. Mr. Rosenberg holds a Bachelor of Science from Boston State College and was awarded his MBA at the University of New Haven.

Paul D. Olivo, M.D., Ph.D.

Chief Medical Officer

Dr. Olivo is a physician scientist with over 40 years of experience in academia and industry in the fields of infectious disease and in vitro diagnostic test development. He holds multiple U.S. patents and has developed many diagnostic tests for viral and autoimmune diseases. He was the President and Chief Scientific Officer  at Apath, LLC, a hepatitis C virus (HCV)-focused company founded by Nobel laureate Dr. Charles Rice. During his tenure at Apath the company developed and licensed many of the virological tools used by the pharmaceutical industry to develop numerous anti-HCV drugs now used to cure HCV. Dr. Olivo was also the VP of R&D at Diagnostic Hybrids, Inc. an IVD manufacturer acquired by Quidel Corp. At Quidel he served as Senior Medical Director.

Dr. Olivo consults for and serves on the boards of multiple early-stage life science companies. He is a Managing Director and Venture Partner at two seed-stage investment firms. He is also an Adjunct Professor at Washington University Medical School in St. Louis. He received his medical and doctoral degrees from the University of Florida. He did his medical residency in Internal Medicine at the University of Wisconsin where he was chief medical resident. He did his postdoctoral training at the National Institutes of Health in the Laboratory of Viral Diseases.

John H. Cellucci

Senior Vice President Operations

John brings to ImmunoProfile® over 30 years of operations experience on a global basis in manufacturing, product development sales, marketing, corporate development, mergers and acquisitions and legal skills. Prior to ImmunoProfile®, he held various senior management positions including executive operational roles at companies like Johnson Controls, Deloitte Consulting and Fedders Air Conditioning and Public Service Electric & Gas. John has been a key manager and leader in a variety of business transactions for Fortune 500 companies. He holds a Bachelor of Arts from Villanova University, an MBA and JD from Widener University and an LLM from a joint program between University of Salzburg Austria and McGeorge School of Law. John holds a PMP certification and is licensed to practice law in the states of PA and NJ.

Scientific Advisory Board

Amanda Kallen

Amanda Kallen

MD

Assistant Professor of Obstetrics, Gynecology, Reproductive Sciences,
Yale Shool of Medicine

Eric Shaw

Eric Shaw

Head Vaccine Clinical Assay Development

Takeda Vaccines, Technical and Strategic Biological Assay expert – Clinical Assay Development and Validation for Vaccines and Therapeutic Biologics Clinical Trials

Scientific Advisory Board

Amanda Kallen

MD

Assistant Professor of Obstetrics, Gynecology, Reproductive Sciences,
Yale Shool of Medicine

Eric Shaw

Head Vaccine Clinical Assay Development

Takeda Vaccines, Technoical and Strategic Biological Assay expert – Clinical Assay Development and Validation for Vaccines and Therapeutic Biologics Clinical Trials

ImmunoProfile® Patents

U.S. Patent No. 10788482 (01707015)

A point of care immunization system based upon microfluidics and microtitration technologies to rapidly test a patient in order to ascertain an immunization profile so that vaccinations can be administered to address identified gaps.
Download Patent

Other links to know more about patent:

Immunization testing system

Patent number: 10788482

ImmunoProfile® Patents

U.S. Patent No. 10788482 (01707015)

A point of care immunization system based upon microfluidics and microtitration technologies to rapidly test a patient in order to ascertain an immunization profile so that vaccinations can be administered to address identified gaps.
Download Patent

Other links to know more about patent:

Immunization testing system

Patent number: 10788482

Here Whenever You Need Us

Hours for Business

Open

Monday to Friday

 9 am to 5 pm EST, USA

Location for Office

Address

4851 Tamiami Trail N
Suite 200
Naples, FL 34103